Mild liver steatosis may be accompanied by disruptions in crucial liver function markers, notably those implicated in iron metabolism, autophagy, and growth factor regulation, such as IGF-1 (Deguise et al., 2021a). This evidence concerns the gene IGF1 and fatty liver disease.